Martin A. Wasserman, PhD
Senior Vice President of Discovery Research and Chief Scientific Officer, AtheroGenics, Inc.

Dr. Martin A. Wasserman serves as Senior Vice President of Discovery Research and Chief Scientific Officer at AtheroGenics, Inc. Prior to joining AtheroGenics, Dr. Wasserman was the Vice President and Senior Distinguished Scientist in the Respiratory and Rheumatoid Arthritis Disease Group within the U.S. Drug Innovation and Approval Organization (R&D) at Aventis Pharmaceuticals, Inc., in Bridgewater, N.J. (1995-2001). He has a B.S. degree in Pharmacy from the Ernst Mario School of Pharmacy at Rutgers University in New Jersey (1963) and M.A. (1971) and Ph.D. (1972) degrees in Pharmacology and Toxicology from the University of Texas Medical Branch in Galveston, Texas (from which he was also honored with the Distinguished Alumnus Award in 1986).

Dr. Wasserman began his biomedical career as a Research Investigator in the Department of Hypersensitivity Diseases Research at Pfizer (formerly Pharmacia) in Kalamazoo, Michigan where he evaluated potential bronchodilators, immunomodulators, prostaglandins and anti-asthmatics in animal models of pulmonary disease (1972-1981). Later he was appointed as Group Director of Pharmacology and Inflammation at GlaxoSmithKline, Inc. (Philadelphia, Pennsylvania) where his early interest in allergy, inflammation, and immunology broadened to include cardiovascular, renal and gastrointestinal research (1981-1988). Dr. Wasserman became Director of Biomedical Evaluation (Human Pharmacology) at the Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, N.J. (1989-1991) and, then, Director of Bronchopulmonary Research at Hoffmann-LaRoche, Inc. in Nutley, New Jersey (1992-1995).

He is presently Adjunct Professor of Medicine at Emory University and formerly held four additional Adjunct Professorships at: The University of Medicine and Dentistry of New Jersey, Rutgers University College of Pharmacy and Philadelphia College of Pharmacy and Sciences and Seton Hall University School of Graduate Medical Education. He is on the Editorial Boards of several journals, e.g., The Journal of Pharmacology and Experimental Therapeutics and The Yearbook of Pharmacology. He has published 79 peer-reviewed research papers, 131 abstracts and 23 book chapters/review articles in the areas of pulmonary, immunology, inflammation, cardiovascular, renal and gastrointestinal research. Additionally, he has been a Visiting Professor at Boston University (1985), Vanderbilt University (1986, 1987) School of Medicine and Medical College of Georgia (2004).